Skip to main content
CELADON PHARMACEUTICALS PLC logo

CELADON PHARMACEUTICALS PLC — Investor Relations & Filings

Ticker · CEL ISIN · GB00BDQYGP38 LEI · 213800YXCATORT475807 IL Manufacturing
Open in API
Filings indexed 128 across all filing types
Latest filing 2024-08-12 Capital/Financing Update
Country GB United Kingdom
Listing IL CEL

About CELADON PHARMACEUTICALS PLC

https://celadonpharma.co.uk/

Celadon Pharmaceuticals PLC is a vertically integrated pharmaceutical company focused on the research, cultivation, manufacturing, and supply of cannabinoid-based medicines. The company operates a licensed, 100,000 sq ft facility with EU-GMP certification for the indoor, hydroponic cultivation of high-THC cannabis and the extraction of cannabinoid Active Pharmaceutical Ingredients (API). Its primary focus is the chronic pain market, and it is conducting an MHRA conditionally approved clinical trial to generate data supporting the use of its medicines for this condition. Additionally, Celadon has an in-house research and development program focused on intellectual property generation and is involved in developing a licensed cannabinoid treatment for Autism Spectrum Disorder through a biopharma partnership.

Recent filings

Filing Released Lang Actions
Update on Operations and Financial Position
Capital/Financing Update Classification · 99% confidence The document is a formal announcement released via RNS (RNS Number : 9875Z) on August 12, 2024, titled "Update on Operations and Financial Position." It discusses operational progress, delays in equity fundraise tranches, updates on a committed credit facility draw down, and the current cash position (£48k as of August 9, 2024). It also mentions that the information contained is 'inside information for the purposes of article 7 of the Market Abuse Regulation (EU) 596/2014' and is being published via RNS, the news service of the London Stock Exchange. This content is a general operational and financial update, not a full annual report (10-K), a quarterly report (IR), or a specific earnings release (ER) focusing only on key figures. It details financing activities (equity fundraise, credit facility) but is broader than just a Capital/Financing Update (CAP). Since it is a general, timely announcement disseminated through the official regulatory news service (RNS) that doesn't fit neatly into the more specific categories like ER, IR, or CAP, the most appropriate classification is the general regulatory announcement fallback category. Given the source (RNS) and the nature of the update (operational and financial status), it aligns best with Regulatory Filings (RNS) as a catch-all for official, non-standardized announcements.
2024-08-12 English
Successful Completion of Eighth Harvest of 2024
Regulatory Filings Classification · 99% confidence The document is clearly identified as originating from 'RNS Number : 4929W' and contains standard regulatory boilerplate language, including references to the London Stock Exchange and the Financial Conduct Authority (FCA). The content is a brief announcement titled 'Successful completion of eighth harvest of 2024' and provides operational updates, not comprehensive financial statements (like 10-K or IR) or a full transcript (CT). Since it is a general regulatory announcement disseminated via the RNS system that doesn't fit into more specific categories like ER, DIV, or DIRS, it falls best under the general Regulatory Filings category (RNS). The length is moderate, but the nature is purely informational/operational news release via the official channel.
2024-07-16 English
Third Admission of Shares
Share Issue/Capital Change Classification · 99% confidence The document is identified by the RNS Number header and the explicit mention of 'RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom.' This indicates a regulatory announcement made via the London Stock Exchange's RNS service. The content specifically announces the 'Third Admission of Shares' and provides details on the total number of voting rights, which relates to capital structure changes and share issuance. While it touches upon share capital changes (SHA), the primary nature of this filing is a general regulatory announcement distributed through the official channel (RNS). Given the options, RNS serves as the best fit for a standard, time-sensitive regulatory disclosure that isn't a specific financial report (like 10-K or IR) or a specific corporate action like a dividend or director dealing. The document length is short (3953 chars), suggesting it is an announcement rather than a full report.
2024-07-15 English
Group of companies' accounts made up to 2023-12-31
Regulatory Filings
2024-07-03 English
Result of AGM
AGM Information Classification · 99% confidence The document explicitly states it is announcing the 'Result of Annual General Meeting' and confirms that 'all resolutions were duly passed'. This directly corresponds to the definition of AGM Information (AGM-R). Although it mentions where full details are set out (the website), the core content is the announcement of the AGM results, making AGM-R the most precise classification over a general Report Publication Announcement (RPA) or Regulatory Filing (RNS).
2024-06-28 English
Second Admission of Shares
Share Issue/Capital Change Classification · 99% confidence The document is identified by the 'RNS Number' header and explicitly states it is provided by 'RNS, the news service of the London Stock Exchange.' The content announces the 'Second Admission of Shares' and provides the total number of voting rights, which is a standard regulatory disclosure. Since this is a general regulatory announcement that doesn't fit specific categories like Capital Change (SHA) or Director's Dealing (DIRS), and it is presented as a brief news item from the exchange's service, the most appropriate classification is the general regulatory filing category, RNS.
2024-06-07 English

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.